Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
23.90
-0.16 (-0.67%)
Nov 26, 2025, 9:51 AM EST - Market open
Fresenius Medical Care AG Market Cap
Fresenius Medical Care AG has a market cap or net worth of $13.89 billion as of November 26, 2025. Its market cap has increased by 10.95% in one year.
Market Cap
13.89B
Enterprise Value
25.67B
1-Year Change
10.95%
Ranking
Category
Stock Price
$23.90
Market Cap Chart
Since December 1, 1998, Fresenius Medical Care AG's market cap has increased from $5.99B to $13.89B, an increase of 131.99%. That is a compound annual growth rate of 3.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 13.77B | 3.63% |
| Dec 31, 2024 | 13.29B | 8.69% |
| Dec 29, 2023 | 12.22B | 27.48% |
| Dec 30, 2022 | 9.59B | -49.57% |
| Dec 31, 2021 | 19.01B | -23.32% |
| Dec 31, 2020 | 24.80B | 9.70% |
| Dec 31, 2019 | 22.60B | 13.87% |
| Dec 31, 2018 | 19.85B | -38.32% |
| Dec 29, 2017 | 32.18B | 24.87% |
| Dec 30, 2016 | 25.77B | 2.18% |
| Dec 31, 2015 | 25.23B | 12.65% |
| Dec 31, 2014 | 22.39B | 3.94% |
| Dec 31, 2013 | 21.54B | 4.62% |
| Dec 31, 2012 | 20.59B | 1.55% |
| Dec 30, 2011 | 20.28B | 18.85% |
| Dec 31, 2010 | 17.06B | 9.93% |
| Dec 31, 2009 | 15.52B | 12.36% |
| Dec 31, 2008 | 13.81B | -10.15% |
| Dec 31, 2007 | 15.37B | 64.77% |
| Dec 29, 2006 | 9.33B | 131.35% |
| Dec 31, 2002 | 4.03B | -31.05% |
| Dec 31, 2001 | 5.85B | -26.55% |
| Dec 29, 2000 | 7.96B | -4.19% |
| Dec 31, 1999 | 8.31B | 20.77% |
| Dec 31, 1998 | 6.88B | 14.97% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 985.53B |
| Johnson & Johnson | 499.06B |
| AbbVie | 409.80B |
| UnitedHealth Group | 295.37B |
| AstraZeneca | 283.06B |
| Merck & Co. | 259.35B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 223.88B |